Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for ARGATROBAN
- A Randomized, Double-Blind Phase 2 Study of VLX-1005 Versus Placebo in Suspected Heparin Induced Thrombocytopenia
- Safety of Argatroban Infusion in Conduction Disturbances
- A Phase I Study of the Co-administration of VLX-1005 and Argatroban in Healthy Human Subjects
- Safety and Feasibility of Argatroban as Anticoagulant in Adults With ECMO
- Safety and Efficacy of Argatroban Applicated in Anticoagulation of V-V ECMO
- Anticoagulation in Critically Ill Patients With COVID-19 (The IMPACT Trial)
- Clinical Study of Argatroban in the Treatment of Acute Progressive Ischemic Stroke
- Improving Neuroprotective Strategy for Ischemic Stroke With Sufficient Recanalization After Thrombectomy by Intra-arterial Cocktail Therapy (INSIST-CT)
- Open-Label, Randomised, Active Controlled, Multi-Centre Phase 3 Study to Evaluate Safety and Efficacy of Danaparoid vs Argatroban
- Argatroban Plus R-tPA for Acute Ischemic Stroke
- Multi-arm Optimization of Stroke Thrombolysis
- Efficacy and Safety of Apixaban in the Treatment of Heparin Induced Thrombocytopenia (HIT)
- Argatroban Combined With Antiplatelet Versus Antiplatelet for Acute Ischemic Stroke
- Argatroban Plus r-tPA for Posterior Circulation Infarction（AR-PCI）
- Thromboprophylaxis After Surgery for Gynecologic Malignancy in China
- Safety and Feasibility of Argatroban, Tissue Plasminogen Activator and Intra-arterial Therapy in Stroke
- Therapeutic Equivalence Between Branded and Generic WARFArin Tablets in Brazil
- Argatroban for Preventing Occlusion and Restenosis After Extracranial Vertebral Artery Stenting
- Direct Thrombin Inhibitors Versus LMWH in Staphylococcus Aureus Bacteraemia
- Argatroban in Critically Ill Patients With Heparin Resistance
- Randomized Controlled Trial of Argatroban With Tissue Plasminogen Activator (tPA) for Acute Stroke
- Retrospective Registry of Patients With Acute Heparin-induced Thrombocytopenia Type II
- Significance of Antibodies to Heparin/Platelet Factor 4 Complex in Vein Graft Patency and Potential Role of Argatroban for Prevention of Vein Graft Occlusion
- Argatroban for Preventing Occlusion and Restenosis After Intracranial and Extracranial Artery Stenting
- Clinical Management of Argatroban in Patients With Heparin Induced Thrombocytopenia Type II
- Argatroban Versus Lepirudin in Critically Ill Patients
- A Comparative Sudy Comparing Argatroban® IV vs Desirudin SC for Suspected HIT With or Without Thrombosis Syndrome
- Study on Safety and Effectiveness of Three Doses of Argatroban as Anticoagulant in Percutaneous Coronary Intervention (PCI)
- Argatroban Stroke Treatment - A Pilot Safety Study
- Efficacy and Safety Study of Argatroban to Treat Heparin-Induced Thrombocytopenia
- Edaravone and Argatroban Stroke Therapy Study for Acute Ischemic Stroke
- Safety and Dosing Evaluation of REG1 Anticoagulation System
- Evaluation of Argatroban Injection in Pediatric Patients Requiring Anticoagulant Alternatives to Heparin
- Pharmacokinetics/Pharmacodynamics of Argatroban Injection in End-Stage Renal Disease Patients Undergoing Hemodialysis
Clinical trials list
click for details